Evidence map›Paper›PMID 42470264›Full record

ArticlePhysiology (Bethesda, Md.)2026

Dietary modulation of CMA: implications for cancer prevention and therapy.

Cecilia Sanchez-Felipe, Esperanza Arias, Julio Madrigal-Matute

Abstract read
In one paragraph

Article in Physiology (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cecilia Sanchez-FelipeDepartamento de Medicina Preventiva y Salud Pública, Universitat de València.
Esperanza AriasDepartment of Medicine, Department of Pathology, Institute for Geroscience, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Julio Madrigal-MatuteDepartamento de Medicina Preventiva y Salud Pública, Universitat de València.ORCID 0000-0002-0894-5450

Funding

Transdisciplinary Research in Energetics and Cancer (TREC) Training GrantR25CA203650 · NCI · YALE UNIVERSITY · PI IRWIN, MELINDA L · 2016 to 2025
$2.9M
Role of CMA failure in NASH progression to Hepatocellular CarcinomaR01DK124308 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI ARIAS-PEREZ, ESPERANZA · 2020 to 2023
$1.5M
HHS | NIH | National Cancer Institute (NCI) R25CA203650HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK124308MEC | Agencia Estatal de Investigación (AEI) PID2024-159272OB-I00MEC | Agencia Estatal de Investigación (AEI) RYC2022-036653-INCI NIH HHS R25 CA203650NIDDK NIH HHS R01 DK124308The Ceriale Family Foundation Junio Scientist AwardThe Keystone Symposia on Molecular and Cellular Biology Fellows ProgramTransdisciplinary Research in Energetics and Cancer Center (TREC)Universitat de València (UV) UV-INV_AE-3649639
6 · The paper itself

Abstract

Chaperone-mediated autophagy (CMA) is a selective lysosomal degradation pathway that links nutrient availability to intracellular proteostasis through the targeted turnover of selective cytosolic proteins. Through this selective control of protein quality, CMA participates in the regulation of metabolic adaptation, cellular homeostasis, and stress responses. CMA is highly responsive to nutritional cues, including caloric restriction (CR), fasting, and changes in macronutrient composition, positioning this pathway as a key mediator of cellular adaptation to metabolic stress. In cancer, CMA displays context-dependent functions that influence tumor metabolism, genomic stability, and survival under adverse microenvironmental conditions. These dual roles suggest that dietary modulation of CMA may shape tumor initiation and progression through effects on cellular proteostasis and metabolic plasticity. In this review, we summarize current knowledge on the molecular mechanisms by which nutritional signals regulate CMA and discuss the physiological implications of nutrition-driven CMA modulation for cancer prevention and therapy.

Identifiers

PMID42470264
PMCPMC13587774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.